1063TiPENGOT-EN9/LEAP-001: A phase III, randomized,...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1063TiPENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer

Marth, C, Vulsteke, C, Rubio, M J, Makker, V, Braicu, E I, McNeish, I A, Radoslaw, M, Ayhan, A, Hasegawa, K, Wu, X, Dutta, L, Xu, C, Keefe, S M, Lee, J, Pignata, S
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz250.071
Date:
October, 2019
File:
PDF, 78 KB
2019
Conversion to is in progress
Conversion to is failed